W. Dalton

发表

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation

JS Damiano, L. Hazlehurst, W. Dalton, 2001, Leukemia.

Mutations in the Fas antigen in patients with multiple myeloma.

T. Landowski, J. Painter, N. Qu, 1997, Blood.

Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells.

J. Tao, L. Moscinski, L. Hazlehurst, 2007, Leukemia.

Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.

P. Meltzer, T. Grogan, W. Dalton, 1990, Laboratory investigation; a journal of technical methods and pathology.

Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis

J. Tao, H. Shu, L. Moscinski, 2009, Leukemia.

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas

X. Zhang, K. Wright, G. Wright, 2012, Oncogene.

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity

X. Zhao, S. Chen‐Kiang, W. Dalton, 2013, Leukemia.

Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

T. Landowski, K. Shain, I. Buyuksal, 2000, Leukemia.

β1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells

W. Dalton, L. Hazlehurst, W. Dalton, 2007, British journal of haematology.

Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin's lymphoma cells

J. Tao, L. Moscinski, L. Hazlehurst, 2007, Leukemia.

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas

W. Tam, K. Wright, J. Tao, 2011, Leukemia.

Detection of multidrug resistance gene expression in multiple myeloma

W. Dalton, 1997, Leukemia.

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

P. Meltzer, T. Grogan, T. Miller, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.

J. Trent, J. Trent, C. Taylor, 1991, British Journal of Cancer.

The research mission in myeloma

S. Jagannath, A. Jakubowiak, N. Munshi, 2009, Leukemia.